Drug intelligence / Profile preview

dexamethasone + Ora-Sweet

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

dexamethasone + Ora-Sweet refers to an oral formulation of the synthetic glucocorticoid dexamethasone using Ora-Sweet as a flavoring and suspending vehicle. This specific combination was evaluated by the IWK Health Centre in a clinical trial (NCT02010008) to treat acute asthma exacerbations in children. The study aimed to determine if a high-concentration (10 mg/mL) dexamethasone solution mixed with Ora-Sweet, which allows for a smaller total liquid volume, would improve patient tolerability by reducing the incidence of vomiting compared to standard 1 mg/mL preparations. Dexamethasone provides therapeutic benefit in asthma through its potent anti-inflammatory effects, mediated by the activation of the glucocorticoid receptor and subsequent modulation of gene expression to decrease pro-inflammatory mediator production.

Brand names
Ora-Sweet
Other names
dexamethasone in Ora-Sweet
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on dexamethasone + Ora-Sweet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + Ora-Sweet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call